ACADIA Pharmaceuticals, Inc. (ACAD)
21.32
+0.37
(+1.77%)
USD |
NASDAQ |
May 21, 16:00
21.32
0.00 (0.00%)
After-Hours: 19:59
ACADIA Pharmaceuticals Research and Development Expense (TTM) : 327.40M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 828.00M |
| Madrigal Pharmaceuticals, Inc. | 451.53M |
| BioMarin Pharmaceutical, Inc. | 721.03M |
| MannKind Corp. | 72.56M |
| Regeneron Pharmaceuticals, Inc. | 5.526B |